For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Pneumococcal disease is an infection caused by the Streptococcus pneumoniae bacteria, which especially affects infants and children below 5 years of age.
Scope of the Report:
This report focuses on the Pneumococcal Polysaccharide Vaccine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The major factors that contribute to the growth of the pneumococcal polysaccharide vaccine market include increasing prevalence of pneumonia globally, improving healthcare infrastructure, rise in government focus on immunization programs for pneumonia, and development of quality vaccines such as PPSV23.
The worldwide market for Pneumococcal Polysaccharide Vaccine is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
- Merck & Co., Inc.
- Pfizer Inc.
- Glaxosmithkline Plc.
- Sanofi Pasteur
- China National Biotec Group
- Astellas Pharma Inc
- Serum Institute of India Pvt. Ltd
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- Single Dose Vial
- Pre-Filled Syringe
Market Segment by Applications, can be divided into
- Children (2-10 Age)
- Adult (10-64 Age)
- Geriatric (More Than 65 Age)
There are 15 Chapters to deeply display the global Pneumococcal Polysaccharide Vaccine market.
Chapter 1, to describe Pneumococcal Polysaccharide Vaccine Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Pneumococcal Polysaccharide Vaccine, with sales, revenue, and price of Pneumococcal Polysaccharide Vaccine, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Pneumococcal Polysaccharide Vaccine, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Pneumococcal Polysaccharide Vaccine market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Pneumococcal Polysaccharide Vaccine sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source